However, Partnership for Safe Medicines Executive Director Shabbir Imber Safdar stated that these votes are a serious setback for patient safety," adding that the Pharmaceutical Compounding Advisory Committee voted to advance substances that FDAs own scientists flagged as lacking adequate evidence of safety, efficacy, or quality
O.OhanadorR.OmoregieE
[16] Chitapanarux I, Chitapanarux T, Traisathit P, et al
The implication is that were confronting an epidemic of vitamin D deficiency that puts us all at risk for cancer, heart disease, diabetes, and depressionand that sunscreen use is the culprit
[2] Additionally, GLP-1 agonists have been shown to reduce markers of systemic inflammation, including C-reactive protein (CRP), in patients with type 2 diabetes and cardiovascular disease, though these reductions are often modest